MoneyWorks4Me

Marksans Pharma informs about half yearly compliance certificate

17 Apr 2018 Evaluate

Marksans Pharma has informed about half yearly Compliance Certificate pursuant to Regulation 40 (9) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. This information pertains to half year ended March 31, 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..